Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
Hiroki Ozawa, Rheumatologist at St.Luke’s International Hospital, shared a post on LinkedIn about a paper by Yuri Hiramatsu et al. published in Rheumatology:
“Real-World Data from Japan: Treat-to-Target Strategy in RA Pregnancy
Sharing new real-world evidence from the Japanese multicentre ANSWER cohort, which analyzed 118 pregnancies in women with rheumatoid arthritis (RA) and evaluated the impact of a treat-to-target (T2T) approach.
Key Insights from Japan
1․ T2T enables both disease control and healthy pregnancy outcomes
85% of patients maintained remission or low disease activity throughout pregnancy.
Tight control translated into excellent outcomes, including a 92.8% full-term delivery rate.
Continued use of pregnancy-compatible bDMARDs (e.g., etanercept, certolizumab pegol) was linked with lower disease activity during later trimesters.
2․ Salazosulfapyridine (SASP) shows a positive neonatal signal
Maternal SASP use in the third trimester was associated with higher birth weights (P=0.003) and a trend toward longer gestational ages (P=0.051).
While causality needs further confirmation, this real-world signal supports SASP as a potentially beneficial option during pregnancy.
Take-home message:
Individualized T2T strategies are feasible and effective in pregnant RA patients, supporting both maternal stability and optimal fetal health.
Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study | Rheumatology | Oxford Academic
For more research summaries and clinical insights, I share quick audio digests here:
Journal Note — Spotify Podcast”
Title: Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study
Authors: Yuri Hiramatsu, Takuya Kotani, Eri Nakamura, Ayaka Yoshikawa, Motomu Hashimoto, Akira Onishi, Kouichi Murata, Natsuki Yamamoto, Kosaku Murakami, Toru Hirano, Yuichi Maeda, Kosuke Ebina, Sho Sendo, Yonsu Son, Hideki Amuro, Ryota Hara, Masaki Katayama, Wataru Yamamoto, Tohru Takeuchi
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 6, 2026, 01:35Alison Wright: BSGE 2026 Highlights Leadership Change and Future Vision
-
May 6, 2026, 01:30Short Menstrual Cycles May Signal Early Ovarian Ageing – Fertility Plus
-
May 6, 2026, 01:27Asma Khalil: Maternal Mental Health Remains a Leading Risk
-
May 5, 2026, 16:55Pregnancy Outcomes in a Recurrent Miscarriage Population After Uterine Surgeries – Fertility and Sterility
-
May 5, 2026, 16:43MAGENTA Oocyte Scores, Morphokinetics and Live Birth – Future Fertility
-
May 5, 2026, 16:34Join Us on 16 September to Explore Challenges in Managing a Successful Fertility Service – BFS
-
May 5, 2026, 16:17Mature Oocyte Retrieval Without an Exogenous Trigger During Stimulation – Fertility and Sterility
-
May 5, 2026, 16:08We Are Delighted to Announce that Fertility 2027 Registration Opens soon – Fertility Conferences
-
May 5, 2026, 15:59Lillian’s Story Highlights Urgency of Recognising Postpartum Preeclampsia – Preeclampsia Foundation